Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Res Child Adolesc Psychopathol ; 51(12): 1933-1944, 2023 12.
Artigo em Inglês | MEDLINE | ID: mdl-37875642

RESUMO

Despite the five million children in the U.S. with an incarcerated parent, there is limited research on risk and protective factors for this population. We analyzed data from the National Survey for Children's Health (2018) to: (1) examine associations among parental incarceration and other adverse childhood experiences (ACEs), (2) characterize the association between parental incarceration and youth mental health outcomes, (3) examine differences in positive childhood experiences (PCEs; collective socialization, community engagement, neighborhood amenities, and family problem solving) by parental incarceration status, (4) examine whether PCEs were protective against mental health problems and if there was an interaction with parental incarceration status, and (5) examine the interaction between PCEs, parental incarceration, and ACEs on mental health problems. Results revealed that children with incarcerated parents had higher odds of experiencing other ACEs, higher odds of having mental health problems, and experienced fewer PCEs compared to children without incarcerated parents. Further, although PCEs were associated with a lower odds of mental health problems for both children with and without incarcerated parents, they did not mitigate the negative impact of parental incarceration on mental health outcomes. While PCEs attenuated the association between ACEs and mental health, parental incarceration status did not significantly moderate the interaction. These results highlight vulnerabilities and potential protective factors for children with incarcerated parents and have important implications for the development of multilevel intervention strategies that seek to promote resilience and reduce risk for this population.


Assuntos
Experiências Adversas da Infância , Criança , Adolescente , Humanos , Pais/psicologia , Saúde Mental , Socialização , Estabelecimentos Correcionais
2.
Emerg Radiol ; 10(4): 173-5, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15290483

RESUMO

The purpose of this paper is to determine the necessity of a dedicated facial bone/orbital computed tomography (CT) scan for fracture surveillance in patients who have suffered blunt head trauma and whose routine nonenhanced head CT scan is negative. It is based on a retrospective review of 115 patients presenting to the Emergency Department at a level I trauma center after blunt head trauma. Included patients underwent both a nonenhanced head CT scan and a dedicated facial bone or orbit CT. Standard nonenhanced head CT protocol was followed for each patient as per department protocol. A positive head CT scan is defined to include either an air-fluid level within the paranasal sinuses or fracture of the maxillary, orbital, or zygomatic osseous structures. A negative scan demonstrates none of these findings. Intracranial/parenchymal pathology was not evaluated in this study. Sixty-five of the 115 patients had a negative head CT scan as defined above. Of these 65 patients, none subsequently had a positive facial bone or orbit CT scan. The sensitivity and negative predictive values of a negative routine nonenhanced head CT scan for fracture surveillance are both 100%. In the setting of blunt trauma, a negative nonenhanced head CT scan precludes the need for a dedicated facial bone or orbital CT scan in the evaluation for orbital, maxillary, or zygomatic fractures. This saves the patient unnecessary radiation exposure, health care costs, and time spent in the emergency radiology department.


Assuntos
Traumatismos Cranianos Fechados/diagnóstico por imagem , Fraturas Maxilares/diagnóstico por imagem , Fraturas Orbitárias/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Fraturas Zigomáticas/diagnóstico por imagem , Adulto , Ossos Faciais/diagnóstico por imagem , Feminino , Traumatismos Cranianos Fechados/complicações , Humanos , Masculino , Órbita/diagnóstico por imagem , Sensibilidade e Especificidade
3.
Int J Pharm ; 265(1-2): 151-7, 2003 Oct 20.
Artigo em Inglês | MEDLINE | ID: mdl-14522128

RESUMO

The objective of this research was to investigate the mechanism(s) of transport of generation 2 (G2) poly (amidoamine) dendrimers across Caco-2 cell monolayers. The contribution of an energy-dependent process such as adsorptive endocytosis was investigated by determining G2 permeability at 4 and 37 degrees C. The contribution of P-gp efflux to transport was examined by determining the apical to basolateral (AB) and basolateral to apical (BA) permeability of 14C-paclitaxel in presence of G2, and by determining AB and BA permeability of G2 in presence of paclitaxel. The permeability of G2 and 14C-mannitol was investigated in the presence of palmitoyl carnitine to determine the contribution of the paracellular pathway. Permeability of G2 at 4 degrees C was significantly (P<0.05) lower than that observed at 37 degrees C. AB and BA permeability of 14C-paclitaxel did not change in the presence of G2. AB and BA permeability of G2 did not change in the presence of paclitaxel. The permeability of G2 and 14C-mannitol increased significantly (P<0.05) in the presence of palmitoyl carnitine, and in addition, 14C-mannitol permeability was increased in presence of G2. The permeability of G2 across Caco-2 cell monolayers appears to involve a combination of paracellular transport and an energy-dependent process, possibly adsorptive endocytosis. G2 dendrimers do not appear to be substrates for the P-gp efflux system.


Assuntos
Materiais Biocompatíveis/farmacocinética , Poliaminas/farmacocinética , Transporte Biológico , Células CACO-2 , Permeabilidade da Membrana Celular , Dendrímeros , Portadores de Fármacos/farmacocinética , Humanos
4.
J Vasc Interv Radiol ; 12(1): 89-94, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11200359

RESUMO

PURPOSE: To determine if the Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) causes damage to normal vein valves. MATERIALS AND METHODS: Ten lateral saphenous veins in five dogs were studied with descending venography with use of a wedge balloon catheter positioned above 48 valves (demonstrating 51 valves) before and after five antegrade passes each with an over-the-wire (0.025-inch), 6.5-F, 9-mm-diameter PTD. Vein diameters were 3.2-11.4 mm (mean, 5.9 mm). Contrast matter was injected at incremental rates from 3 to 15 mL/min during continuous pressure monitoring. Imaging was performed with digital subtraction angiography at a rate of 1 frame/sec. The time to valve reflux was determined by noting the frame at which reflux was first seen through the valve. The time to reflux and pressure required to reflux were compared before and after the PTD passes. All vessels were explanted and evaluated histologically for presence or absence of endothelial loss, thrombus formation, inflammation, or valve degeneration. Four veins in two animals were studied with venography to determine the variability of the venographic method. These veins thrombosed during venography and therefore served as positive pathologic controls. In two animals, one vein was studied with venography and one was not studied to provide pathologic controls. RESULTS: With use of two physiologic tests of valve function, 77% of valves had minimal or no damage as assessed by valve competency and 80% had minimal or no damage as demonstrated by the change in the pressures the valve can withstand before reflux. Twenty-six of 51 valves (51%) had no difference or later reflux after PTD use. Thirteen (26%) refluxed 1 second earlier after PTD use and 12 (23%) refluxed > or =2 seconds earlier (six at 2, four at 3, and two at 4). Four of the six valves with more than a 2-second difference in reflux times were in valves with diameters less than 4.2 mm. All these vessels were smaller than 7 mm in diameter. Twenty-one of 48 valve levels (44%) had no difference or sustained higher pressures before reflux after PTD use. Seventeen (36%) had a pressure drop of <10 mm Hg; five (10%) had drops of 12-24 mm Hg; and five (10%) had drops of more than 40 mm Hg. There was a significant difference in endothelial loss, thrombus formation, and inflammation between experimental veins, the veins with thrombus, the venography controls, and the normal vein controls. There was significant difference only in terms of inflammation when the experimental group was compared to the thrombosis group. CONCLUSION: The antegrade use of the PTD across normal canine vein valves does not cause physiologically significant damage in valves 7 mm or larger in diameter in this animal model.


Assuntos
Terapia Trombolítica/instrumentação , Veias/fisiologia , Animais , Cateterismo Periférico , Cães , Flebografia
6.
J Pharm Sci ; 89(7): 867-75, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10861587

RESUMO

Felbamate (FBM) is a novel antiepileptic drug (AED) and neuroprotectant (NP) compound that interacts with strychnine-insensitive (SI) glycine receptors in brain (IC(50) = 374 microM). FBM concentrations required to interact with SI glycine receptors are consistent with brain levels following oral and intraperitoneal administration of AED and NP doses. Because of the solubility limits of FBM, an intravenous (iv) form has not been developed. Nevertheless, an iv form could be important for the treatment of disorders such as status epilepticus and neuronal damage due to hypoxic/ischemic events. Substituted diketopiperazines precipitate in acid to form microspherical particles of uniform size ( approximately 2 microm). The microsphere system entraps drugs on precipitation and dissolves near physiological pH to release the drug cargo. Therefore, microspheres were used to produce an iv formulation of FBM. Mice were administered the FBM/microsphere (20-60 mg/kg FBM) and tested for protection against tonic extension seizures using maximal electroshock. The FBM/microsphere was effective in a time- and dose-dependent manner following iv administration. The median effective dose (ED(50)) for protection against MES seizures at 30 min was 27.2 mg/kg [95% confidence interval (CI) = 20.8-33.4, slope = 6.5]. The ED(50) for minimal motor impairment at 30 min was 167 mg/kg (95% CI = 155-177, slope = 28.1). Thus, the feasibility of encapsulating FBM or similar aqueous insoluble compounds in a microsphere system with delivery by the iv route for treatment of epilepsy and various central nervous system disorders has been clearly demonstrated. Studies were performed in accordance with the Guide for the Care and Use of Laboratory Animals.


Assuntos
Anticonvulsivantes/administração & dosagem , Fármacos Neuroprotetores/administração & dosagem , Propilenoglicóis/administração & dosagem , Animais , Cromatografia Líquida de Alta Pressão , Portadores de Fármacos , Eletrochoque , Felbamato , Fumaratos/química , Injeções Intravenosas , Masculino , Camundongos , Microscopia Eletrônica de Varredura , Microesferas , Tamanho da Partícula , Fenilcarbamatos , Piperazinas/química , Propriedades de Superfície
7.
Hum Reprod ; 15(5): 1061-4, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10783352

RESUMO

Assisted zona hatching (AZH) has been used in IVF programmes for several years. Recently one group has reported successful pregnancies after transfer of zona-free blastocysts. The aim of our study was to evaluate outcomes after transfer of zona-free day 3 embryos. Two groups of women undergoing intracytoplasmic sperm injection (ICSI) were included in the study. Group A consisted of 52 women under the age of 40 years undergoing their first ICSI attempt. They were alternately randomized to receive zona-free embryos (27 women) and zona-intact embryos (25 women). The second group (group B) included 71 women with a poor prognosis, as defined by age 40 years or more, and/or at least two previous failed IVF/ICSI attempts. They were randomized in a 3:4 ratio (30 zona-free, 41 zona-intact). Acid Tyrode's solution was used to remove the zona pellucida before embryo transfer on day 3 after oocyte collection. The pregnancy rate in group A was not significantly improved when the zona pellucida was removed. However, in the poor prognosis group B, zona removal resulted in a significantly higher pregnancy rate when compared with controls (23 versus 7.3%). We conclude that complete removal of the zona pellucida can improve pregnancy rates in women with poor IVF/ICSI prognosis.


Assuntos
Transferência Embrionária/métodos , Injeções de Esperma Intracitoplásmicas/métodos , Adulto , Embrião de Mamíferos/fisiologia , Feminino , Humanos , Pessoa de Meia-Idade , Gravidez , Taxa de Gravidez , Gravidez Múltipla , Estudos Prospectivos , Soluções , Resultado do Tratamento , Zona Pelúcida
8.
Br J Obstet Gynaecol ; 105(2): 200-5, 1998 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9501787

RESUMO

OBJECTIVE: To audit the epidemiology, management and outcome of vulval cancer in the West Midlands. DESIGN: A retrospective population based study using information obtained from Cancer Intelligence Unit records. SETTING: The West Midlands Health Region. SAMPLE: Five hundred and six women with vulval carcinoma notified to the Cancer Intelligence Unit, during two three-year periods: 1980-1982 and 1986-1988; 411 women had a proven histological diagnosis of squamous cell carcinoma of the vulva. RESULTS: Histology was available for 454/506 women (90%); 411/454 women (91%) had squamous cell carcinoma: these formed the study population. The women were treated at 35 hospitals, 16 of which averaged one case or less per year. The median age at diagnosis was 74 years. Presentation was delayed by more than one year in 63/284 women with data (22%), and 97/284 cases (34%) had more than one symptom. A biopsy was taken in 268 women (65%) and surgery was the primary treatment in 344/411 cases (84%). Fifteen different operations were used. Simple vulvectomy (35%) and radical vulvectomy with bilateral inguinal lymphadenectomy (34%) were the commonest surgical procedures; 190/344 (55%) had a lymphadenectomy; of these 102 women had negative node histology and 78 women had nodal metastases, with results not recorded in 10 cases. Overall, only 46% of all women (190/411) studied had a lymphadenectomy. Recurrence was recorded in 123/411 women (30% of the total). Univariate analysis showed significantly worse five-year survival for older age, advanced stage, incomplete excision, poor differentiation, lack of lymph node resection, positive lymph node pathology and treatment in a hospital with less than 20 cases in total. A multivariate analysis using Cox proportional hazards model identified the first five factors as independent predictors of five year survival. Omission of lymphadenectomy was independently associated with poorer survival (RR 2.17, 95% CI 1.53-3.07). CONCLUSIONS: There is wide variation in the management of vulval cancer with inadequate usage of lymphadenectomy and many centres treating few cases. Survival analysis shows prognostic variables as expected; omission of lymphadenectomy adversely affects survival.


Assuntos
Carcinoma de Células Escamosas/terapia , Melanoma/terapia , Neoplasias Vulvares/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma Basocelular/mortalidade , Carcinoma Basocelular/patologia , Carcinoma Basocelular/terapia , Carcinoma de Células Escamosas/mortalidade , Carcinoma de Células Escamosas/patologia , Inglaterra/epidemiologia , Feminino , Humanos , Melanoma/mortalidade , Melanoma/patologia , Pessoa de Meia-Idade , Recidiva Local de Neoplasia , Estadiamento de Neoplasias , Estudos Prospectivos , Análise de Sobrevida , Resultado do Tratamento , Neoplasias Vulvares/mortalidade , Neoplasias Vulvares/patologia
10.
Pediatr Pathol ; 14(6): 997-1003, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-7855019

RESUMO

Chorioamnionitis is a frequent finding in the placenta in second-trimester premature labor. Seventy-six archival perinatal and fetal autopsies between 15 and 28 weeks of gestation with a morphologic diagnosis of chorioamnionitis were reviewed. Of the 76 cases, 52 (68%) had inflammatory cells in the lungs, which is higher than the reported incidence of clinical infection in neonates with chorioamnionitis. In 23 cases there were peribronchial lymphocytic hyperplasia and neutrophils in the airspaces, in 8 there was a lesser degree of interstitial inflammation as well as luminal neutrophils, and in 21 (40%) there were neutrophils in the airspaces only. To determine whether the neutrophils in the airspaces in the latter were maternal or fetal in origin, the lung sections of seven male fetuses in the group were examined by in situ hybridization for the Y repeat probe pHY 2.1, together with appropriate controls. Two of the tests were technical failures. The remaining five, and the positive controls, showed positivity for pHY 2.1 in 70-86% of luminal neutrophils. We conclude that luminal neutrophils in fetal lungs in this situation are fetal in origin.


Assuntos
Corioamnionite/patologia , Doenças Fetais/patologia , Pneumonia/patologia , Feminino , Marcadores Genéticos , Idade Gestacional , Humanos , Hibridização In Situ , Masculino , Neutrófilos/patologia , Pneumonia/congênito , Gravidez , Estudos Retrospectivos , Cromossomo Y
11.
Science ; 240(4849): 204-7, 1988 Apr 08.
Artigo em Inglês | MEDLINE | ID: mdl-2832947

RESUMO

Genetically transformed maize plants were obtained from protoplasts treated with recombinant DNA. Protoplasts that were digested from embryogenic cell suspension cultures of maize inbred A188 were combined with plasmid DNA containing a gene coding for neomycin phosphotransferase (NPT II) next to the 35S promoter region of cauliflower mosaic virus. A high voltage electrical pulse was applied to the protoplasts, which were then grown on filters placed over feeder layers of maize suspension cells (Black Mexican Sweet) and selected for growth in the presence of kanamycin. Selected cell lines showed NPT II activity. Plants were regenerated from transformed cell lines and grown to maturity. Southern analysis of DNA extracted from callus and plants indicated the presence of the NPT II gene.


Assuntos
Engenharia Genética/métodos , Zea mays/genética , Permeabilidade da Membrana Celular , Células Cultivadas , DNA/análise , DNA Recombinante , Eletricidade , Canamicina Quinase , Fosfotransferases/metabolismo , Plasmídeos , Transformação Genética
12.
Am Heart J ; 106(6): 1353-7, 1983 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-6650357

RESUMO

Propranolol is an effective drug for patients with angina and has been shown to favorably alter exercise ejection fraction and myocardial perfusion images in patients with coronary disease. A characteristic effect of propranolol is reduction in exercise heart rate (HR). Twenty men with coronary disease (10 with prior infarction), angina-limited exercise tests, abnormal myocardial blood flow distribution images (MBFDI) (201thallium) during exercise, and normal resting ejection fractions underwent treadmill exercise testing with imaging on three occasions. Control maximal exercise was performed initially with measurement of MBFDI. Propranolol, 40 mg by mouth four times a day, was administered for a week with exercise repeated to the same workload. A third study, with men off propranolol, was undertaken with exercise continued only to the HR obtained while the men were taking propranolol (submaximal exercise). All men had improvement in MBFDI while receiving propranolol (men without infarction +780 +/- 88 [average +/- SEM] normalized count rate difference between control and propranolol; men with infarction +724 +/- 73 normalized counts). Greater count differences were noted when control exercise and HR-controlled, submaximal exercise MBFDI were compared with a greater difference in men with infarction (+1094 +/- 89 normalized counts) than for men without infarction (+896 +/- 88 normalized counts). Results suggest that propranolol improves MBFDI during exercise in men with angina, but that submaximal exercise results in more normal MBFDI than does propranolol for exercise to the same HR.


Assuntos
Angina Pectoris/diagnóstico por imagem , Circulação Coronária/efeitos dos fármacos , Doença das Coronárias/diagnóstico por imagem , Esforço Físico , Propranolol/farmacologia , Angina Pectoris/tratamento farmacológico , Angina Pectoris/fisiopatologia , Doença das Coronárias/tratamento farmacológico , Doença das Coronárias/fisiopatologia , Coração/diagnóstico por imagem , Coração/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Humanos , Masculino , Infarto do Miocárdio/diagnóstico por imagem , Propranolol/uso terapêutico , Radioisótopos , Cintilografia , Tálio
13.
Circulation ; 66(2): 297-302, 1982 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7094240

RESUMO

Recent studies have shown that blood flow during closed-chest cardiopulmonary resuscitation (CPR) results primarily from generalized changes in intrathoracic pressure rather than direct compression of the heart. Since ascending aortic and right atrial pressures rise and fall synchronously and to comparable levels during CPR, we hypothesized that the absence of a pressure difference across the coronary vascular bed during CPR precludes coronary blood flow. To test this hypothesis, we compared high-fidelity ascending aortic and right atrial pressures and carotid and coronary blood flow (electromagnetic flowmeters) during closed-chest CPR in 12 fibrillating dogs. Chest compression force was increased from 40 to 140 pounds in 20-pound increments using a pneumatic chest compression device. Although ascending aortic and right atrial pressures were always similar, high-compression-force CPR produced small mean pressure differences across the coronary vascular bed (5.6 +/- 0.8 mm Hg [+/- SEM] at 140 pounds). These pressure differences were accompanied by low levels of coronary blood flow. However, coronary flow was less than 1% control (prearrest) values whenever chest compression force was less than 100 pounds, and carotid flow exceeded coronary flow under all conditions (carotid and coronary flows at 140 pounds = 26.2 +/- 6.4% and 4.3 +/- 2.0% of prearrest values, respectively, p less than 0.01). We conclude that generalized changes in intrathoracic vascular pressures during closed-chest CPR promote carotid but not coronary blood flow. High-compression-force CPR produces small pressure differences across the coronary vascular bed, allowing low levels of coronary flow. However, even high-compression-force CPR is over six times more effective in maintaining carotid flow than coronary flow.


Assuntos
Circulação Coronária , Ressuscitação , Animais , Aorta/fisiologia , Função Atrial , Velocidade do Fluxo Sanguíneo , Pressão Sanguínea , Artérias Carótidas/fisiologia , Cães
15.
Appl Opt ; 6(10): 1767-72, 1967 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-20062300

RESUMO

An analysis was performed to determine the radiation transmitting characteristics of a circularly reflecting duct with a collimated beam of rays entering at one end. Data were obtained for various angles of beam incidence, duct included angle, and ratios of the radii of the two walls. Both the over-all energy transmitting characteristics and the local energy absorption distribution were determined.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...